PULSE NEWS WIRE
Clear, Actionable Intelligence
<2 min
Avg Latency
24/5
Coverage

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure from was processed by Pulse News Wire on February 19, 2026. It represents a primary source document for Japanese Corporate sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

Carna Biosciences,Inc. Announces Amendment to Articles of Incorporation

Source disclosure: February 19, 2026 Carna Biosciences,Inc. [4572.T] TOKYO, Feb 19 (Pulse News Wire) -- Carna Biosciences, Inc. (4572.T), represented by President and CEO Yoshino Koichiro, announced today that its board of directors has resolved to propose amendments to the company's articles of incorporation at its upcoming 23rd Annual General Meeting scheduled for March 25, 2026. The proposed changes aim to increase the total number of shares the company is authorized to issue, the

Share this disclosure: Share on X Share on LinkedIn